SCHEMBL3016030

SCHEMBL3016030

COc1ccc2c(n1)N(c1ccc3c(c1)CCC(N(Cc1cc4c(cn1)OCCO4)C(=O)O)C3)C(=O)CN2

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 13/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3024834 0.81 KCNH2 (0.47) KCNH2
SCHEMBL3025535 0.75 KCNH2 (0.39) KCNH2
SCHEMBL3024862 0.74 CA1 (0.39)
SCHEMBL3016694 0.73 KCNH2 (0.37) KCNH2
SCHEMBL3016687 0.73 KCNH2 (0.37) KCNH2
SCHEMBL3013221 0.73 MCHR1 (0.35) KCNH2
SCHEMBL3028019 0.73 MCHR1 (0.35) KCNH2
SCHEMBL3028539 0.72 KCNH2 (0.36) KCNH2
SCHEMBL3324223 0.71 KCNH2 (0.38) KCNH2
SCHEMBL3724009 0.69 GAA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197679-A1 COMPOUNDS GLAXO GROUP LIMITED 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197679-A1 COMPOUNDS NRDC, MRPL21, NISCH KCNH2 2445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.